Schistosomiasis is the second most important parasitic disease of public health importance in Africa, affecting over 50 million children aged <5 years old. Schistosomiasis control has focused on treating school-aged children (>6 years) and adults through mass drug administration (MDA). Following the recent development of a paediatric praziquantel (PZQ) formulation for children aged <5 years, there are now concerted efforts to determine optimal and effective ways to integrate treatment of these children into national schistosomiasis control programmes. In this opinion article we outline the pathway for successful drug access, delivery, and mainstreaming of the new formulation in endemic country health systems. Effective and sustained paediatric schistosomiasis treatment is an important target of the 2030 World Health Organization (WHO) neglected tropical diseases (NTDs) roadmap.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pt.2024.06.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case report of rare presentation of schistosomiasis: delayed diagnosis of genitourinary schistosomiasis in an adolescent.
Pediatr Med Chir
January 2025
Department of Pediatric Surgery and Pediatric Minimally Invasive Surgery and New Technologies, San Bortolo Hospital, Vicenza.
Schistosomiasis is a tropical infection endemic to developing nations that can result in chronic liver damage, renal failure, infertility, and bladder cancer. Genitourinary localization is marked by dysuria, visible hematuria, and urinary obstruction. We present the case of a 17-year-old male adolescent from a rural area of Central Africa, who arrived in Italy two years prior, exhibiting hematuria and urinary symptoms.
View Article and Find Full Text PDFCerebral schistosomiasis in a 3-year-old girl due to : a case report.
Front Immunol
December 2024
Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Introduction: Cerebral schistosomiasis is a rare but severe manifestation of infection, often leading to significant neurological impairment. This case report details the clinical presentation, diagnostic challenges, and treatment of a 3-year-old girl with cerebral schistosomiasis in Sichuan, China.
Case Description: A 3-year-old girl from a rural area in Sichuan, China, presented with a 3-month history of unstable walking, left facial paralysis, drowsiness, and intermittent fever.
Efficacy of Treatments in Reducing Facial Erythema in Rosacea: A Systematic Review.
J Cutan Med Surg
October 2024
Division of Pediatric Dermatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Rosacea is a chronic inflammatory skin condition that affects over 5% of individuals worldwide. Its clinical presentation is characterized by an array of features, including erythema, papules and pustules, phymatous changes, telangiectasia, and ocular manifestations. Specifically, the multifaceted manifestation of erythema varies widely in intensity and distribution.
View Article and Find Full Text PDFPleural parasite infection presenting with an isolated pleural effusion misdiagnosed as tuberculosis: a case report.
Diagn Microbiol Infect Dis
December 2024
Department of Tuberculosis, Guiyang Public Health Clinical Center, Guiyang 550001, Guizhou Province, PR China. Electronic address:
Pleural parasitic infection is an extremely rare disease of the pleura caused by a variety of parasites, with paragonimiasis infection being the most common. The lack of specific clinical symptoms for paragonimiasis makes it easy to misdiagnose as tuberculosis, causing unnecessary drug-related adverse effects and financial burdens from incorrect treatment. We report a case of a pediatric patient presenting with an isolated pleural effusion that was misdiagnosed as tuberculosis; the patient was eventually diagnosed with pleuropulmonary paragonimiasis infection after immunologic and serologic tests.
View Article and Find Full Text PDFEffectiveness of the Antiparasitic Combination of Albendazole and Praziquantel As Compared With Albendazole Monotherapy in the Treatment of Neurocysticercosis in Children: A Systematic Review and Meta-Analysis.
Cureus
July 2024
Department of Dermatovenereology, Ratna Dewi Principal Clinic, Bekasi, IDN.
Article Synopsis
- * This study investigates whether a combination therapy of albendazole and praziquantel is more effective than albendazole alone in treating pediatric neurocysticercosis, following strict review and analysis protocols.
- * Researchers conducted a systematic review that assessed various randomized controlled trials and quantitatively analyzed the results, utilizing statistical models to compare treatment effectiveness based on lesion resolution in children.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!